Olema Pharmaceuticals (OLMA) Earnings Analysis
Olema Pharmaceuticals (OLMA) next reports earnings on 2026-08-10, consensus EPS -0.53 USD. Last quarter (2026-03-16) it beat with EPS -0.5 USD vs -0.51 USD est (+2%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -5.69.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does OLMA next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -0.53 USD |
| Revenue estimate | n/a |
OLMA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-16 | -0.5 USD | -0.51 USD | +2% | Beat |
| 2025-11-10 | -0.49 USD | -0.44 USD | -11.4% | Miss |
| 2025-08-11 | -0.51 USD | -0.43 USD | -18.6% | Miss |
| 2025-03-18 | -0.51 USD | -0.63 USD | +19% | Beat |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
OLMA valuation and analyst view
| Trailing P/E | -5.69 |
|---|---|
| Trailing EPS | -1.80108 USD |
| Price / book | 2.46 |
| Dividend yield | 0.00% |
| Market cap | 0.99B |
| Analyst consensus | Buy (8 buy / 0 hold / 0 sell) |
| Avg price target | 35 USD |
Related research pages
Frequently asked questions
When is Olema Pharmaceuticals (OLMA)'s next earnings date?
Olema Pharmaceuticals is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.53 USD.
Did OLMA beat earnings last quarter?
In its 2026-03-16 report, OLMA posted EPS of -0.5 USD versus a -0.51 USD estimate — a beat of 2%.
What is OLMA's earnings track record?
Over the last 4 reported quarters with consensus data, OLMA beat estimates 2 times (50%).
What is OLMA's current P/E ratio and EPS?
OLMA trades at a trailing P/E of -5.69 on trailing EPS of -1.801078049555945 USD.
What do analysts rate OLMA?
Analyst consensus is "Buy" across 8 ratings (0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 35 USD.